Christopher Mutz - Feb 28, 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
HEAD OF RARE DISEASE
Signature
/s/ Christopher Mutz, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Feb 28, 2023
Transactions value $
$0
Form type
4
Date filed
4/4/2023, 08:07 PM
Previous filing
Feb 17, 2023
Next filing
Mar 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Award $0 +17.4K +46.12% $0.00 55K Feb 28, 2023 Direct F1
transaction ANIP Common Stock Award $0 +11.6K +21.04% $0.00 66.6K Feb 28, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023.
F2 These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.

Remarks:

Exhibit-24 - Power of Attorney